T1	intervention 35 73	wearable technology-based intervention
T2	total-participants 731 733	83
T3	eligibility 734 841	inactive, postmenopausal women diagnosed with stage I-III breast cancer who had completed primary treatment
T4	control 915 928	control group
T7	total-participants 1169 1171	80
T5	outcome 1418 1477	total sitting time and prolonged bouts (≥20 min) of sitting
T6	outcome 1284 1288	MVPA
